BlackRock Fund Advisors’s Genomic Health, Inc. GHDX Stock Holding History

BlackRock Fund Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$30.1M	Buy	1,023,933 +109,916	+12%	+$3.35M	0.01%	1963
2016 Q3	$26.4M	Buy	914,017 +47,996	+6%	+$1.34M	0.01%	1935
2016 Q2	$22.4M	Buy	866,021 +17,588	+2%	+$467K	0.01%	1965
2016 Q1	$21M	Buy	848,433 +34,729	+4%	+$953K	﹤0.01%	1964
2015 Q4	$28.6M	Sell	813,704 -69,184	-8%	-$1.85M	0.01%	1830
2015 Q3	$18.7M	Buy	882,888 +49,105	+6%	+$1.27M	﹤0.01%	2031
2015 Q2	$23.2M	Buy	833,783 +9,532	+1%	+$269K	0.01%	2022
2015 Q1	$25.2M	Buy	824,251 +23,750	+3%	+$755K	0.01%	1948
2014 Q4	$25.6M	Buy	800,501 +56,566	+8%	+$1.84M	0.01%	1913
2014 Q3	$21.1M	Buy	743,935 +5,721	+0.8%	+$160K	0.01%	1931
2014 Q2	$20.2M	Sell	738,214 -57,644	-7%	-$1.53M	0.01%	2016
2014 Q1	$21M	Buy	795,858 +32,429	+4%	+$930K	0.01%	1972
2013 Q4	$22.3M	Sell	763,429 -4,899	-0.6%	-$155K	0.01%	1932
2013 Q3	$23.5M	Buy	768,328 +106,001	+16%	+$3.55M	0.01%	1858
2013 Q2	$21M	Buy	+662,327	New	+$21.8M	0.01%	1829

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BlackRock Fund Advisors's GHDX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Genomic Health, Inc. (GHDX) stake by 12% in Q4 2016, buying an estimated $3.35M and bringing the position to 1,023,933 shares worth $30.1M. The position accounts for 0.01% of the portfolio, ranked #1963.

BlackRock Fund Advisors first reported a position in GHDX in Q2 2013 and has held it in 15 quarters since. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

BlackRock Fund Advisors held 1,023,933 shares of Genomic Health, Inc. worth $30.1M as of Q4 2016.
BlackRock Fund Advisors bought 109,916 Genomic Health, Inc. shares in Q4 2016, an estimated $3.35M.
Genomic Health, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1963 holding.
BlackRock Fund Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 15 quarters since.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.